Expression of Panx1 gene in non-small cell lung cancer and bioinformatics analysis of biological function
-
摘要: 目的 探讨泛连接蛋白1基因在人非小细胞肺癌(non-small cell lung cancer,NSCLC)中表达和预后关系。 方法 首先在癌症基因组图谱数据库(TCGA)中对Panx1基因差异表达情况进行分析。在STRING数据库中构建Panx1基因编码蛋白相互作用网络。对Panx1基因功能进行富集和注释,并分析相关信号通路。根据Panx1基因在患者癌组织中的表达水平分为高表达和低表达组,分析高低表达组生存期差异有无统计学意义。同时选取NSCLC患者61例,采用免疫组织化学法检测患者手术标本中癌和癌旁正常组织中Panx1表达水平,分析比较Panx1表达与患者临床病理特征及预后的关系。 结果 Panx1基因在NSCLC患者癌组织中表达水平明显高于正常肺组织;Panx1基因在不同分期NSCLC患者中差异存在统计学意义(F=3.300,P=0.020)。Panx1基因编码产物主要参与了多器官发育、细胞间交流和对刺激的反应生物学过程;信号通路主要富集于细胞增殖信号通路、凋亡信号通路和钙离子相关信号通路。PAFAH1B2与Panx1基因表达水平呈正相关(r=0.650,P=0.023),而C22orf32与Panx1基因表达呈负相关(r=-0.340,P=0.032)。Panx1基因高表达与NSCLC患者总生存(OR)相关,高表达组OS低于低表达组(HR=1.400,P=0.001),而Panx1基因表达水平与患者无疾病进展生存(DFS)无明显相关性。亚组分析显示,Panx1基因表达与肺腺癌OS生存有关(HR=1.400,P=0.017)。Panx1表达水平与NSCLC患者TNM分期(χ2=7.244,P=0.007)和纵隔淋巴结转移有关(χ2=7.582,P=0.006)。 结论 Panx1基因在非小细胞肺癌患者肿瘤组织中表达水平上调,高表达与患者的总生存期较短有关。Abstract: Objective To investigate the relationship between the expression of Pan connexin 1 gene and prognosis in human non-small cell lung cancer(NSCLC). Methods The differential expression of Panx1 gene was analyzed in TCGA. The interaction network of Panx1 gene coding protein was constructed in the STRING database. The function of Panx1 gene was enriched and annotated, and the related signal pathway was analyzed. According to the expression level of Panx1 gene in cancer tissues, the patients were divided into high expression group and low expression group. At the same time, 61 patients with NSCLC were selected to detect the expression of Panx1 in cancer and normal tissues adjacent to cancer by immunohistochemistry. The relationship between the expression of Gpx1 and the clinicopathological characteristics and prognosis of patients was analyzed and compared. Results The expression level of Panx1 gene in NSCLC was significantly higher than that in normal lung tissue, and there was significant difference in NSCLC and Panx1 gene in different stages of NSCLC(F=3.300, P=0.020). The coding products of Panx1 gene were mainly involved in the biological processes of multiple organ development, cell-cell communication and response to stimulation. The signaling pathways were mainly enriched in cell proliferation signaling pathway, apoptosis signaling pathway and calcium related signaling pathway. There was a positive correlation between pafah1 b2 and Panx1 gene expression(r=0.650, P=0.023). However, c22 orf32 was negatively correlated with Panx1 gene expression(r=-0.340, P=0.032). The total survival(OR) of NSCLC patients with high expression of Panx1 gene was significantly correlated. The OS of high expression group was lower than that of low expression group(HR=1.400, P=0.001), while the expression level of Panx1 gene was not significantly correlated with disease free progression survival(DFS). Subgroup analysis showed that Panx1 gene expression was related to OS survival of lung adenocarcinoma(HR=1.400, P=0.017). Panx1 expression was related to TNM stage(χ2=7.244, P=0.007) and mediastinal lymph node metastasis(χ2=7.582, P=0.006) in NSCLC patients. Conclusion The expression of Panx1 gene is up regulated in non-small cell lung cancer, whihc is related to the short survival time of patients.
-
Key words:
- Non-small cell lung cancer /
- Panx1 gene /
- Survival analysis /
- Signaling pathway
点击查看大图
计量
- 文章访问数: 285
- HTML全文浏览量: 46
- PDF下载量: 8
- 被引次数: 0